InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
T+90 hit rate
0%
T+90 mean return
-16.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by ADAMS R MARK, Chief Operating Officer. Insider active across 1 company, notably Adaptive Biotechnologies Corp. In total, 18 filings have been recorded. Breakdown: 0 buy · 14 sells. Total volume traded: €800k. Activity tracked since 14 June 2021. The latest transaction was filed on 10 April 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
817 shares@ US$8.500.4% of flowCommon StockSEC:0001062993-23-009085:0
88,652 shares0Common StockSEC:0001062993-23-006327:0
995 shares@ US$8.500.5% of flowCommon StockSEC:0001209191-23-003052:0
841 shares@ US$7.610.4% of flowCommon StockSEC:0001209191-22-053372:0
2,284 shares@ US$7.131.1% of flowCommon StockSEC:0001209191-22-053372:1
825 shares@ US$9.530.5% of flowCommon StockSEC:0001209191-22-041730:0
831 shares@ US$13.170.0005% mcap0.7% of flowCommon StockSEC:0001209191-22-023916:0
74,135 shares0Common StockSEC:0001209191-22-017392:0
1,021 shares@ US$23.321.4% of flowCommon StockSEC:0001209191-22-002766
1,021 shares@ US$23.320.0010% mcap1.5% of flowCommon StockSEC:0001209191-22-002766:0
1,324 shares@ US$32.470.0018% mcap2.6% of flowCommon StockSEC:0001209191-21-060116:0
1,324 shares@ US$32.472.5% of flowCommon StockSEC:0001209191-21-060116
871 shares@ US$39.420.0014% mcap2.0% of flowCommon StockSEC:0001209191-21-046083:0
871 shares@ US$39.422.0% of flowCommon StockSEC:0001209191-21-046083
14,583 shares@ US$28.1023.1% of flowCommon StockSEC:0001209191-21-042290
14,583 shares@ US$28.100.017% mcap23.8% of flowCommon StockSEC:0001209191-21-042290:0
8,914 shares@ US$38.770.014% mcap19.8% of flowCommon StockSEC:0001209191-21-041088:0
8,914 shares@ US$38.7719.2% of flowCommon StockSEC:0001209191-21-041088
18 of 18 declarations
About ADAMS R MARK
R. Mark Adams is the Chief Operating Officer at Adaptive Biotechnologies Corp. He oversees the daily operations of the company and ensures that processes are optimized to meet strategic objectives. Adams plays a key role in implementing operational strategies and continuously improving performance.
